iZafe Group AB gets a new international strategic shareholder
Kurs
+16,50%
Likviditet
4,59 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-02-16 | 08:30 | Bokslutskommuniké 2025 |
| 2025-11-03 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-29 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-30 | N/A | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2025-05-28 | N/A | Årsstämma |
| 2025-04-25 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-14 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-31 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2024-05-30 | - | Årsstämma |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-12-21 | - | Extra Bolagsstämma 2024 |
| 2023-11-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-12 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-06 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2023-04-05 | - | Årsstämma |
| 2023-02-03 | - | Bokslutskommuniké 2022 |
| 2022-11-07 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-05 | - | Extra Bolagsstämma 2022 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-15 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2022-06-14 | - | Årsstämma |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-18 | - | Bokslutskommuniké 2021 |
| 2021-11-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-09-23 | - | Extra Bolagsstämma 2021 |
| 2021-08-30 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-28 | - | Årsstämma |
| 2021-06-15 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2020-11-09 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-26 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2020-06-25 | - | Årsstämma |
| 2020-05-11 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-10 | - | Årsstämma |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-12-18 | - | Extra Bolagsstämma 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-29 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-12 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2018-04-11 | - | Årsstämma |
| 2018-03-22 | - | Bokslutskommuniké 2017 |
| 2017-08-29 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-26 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2017-04-25 | - | Årsstämma |
| 2017-02-24 | - | Bokslutskommuniké 2016 |
| 2016-11-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-10-19 | - | Extra Bolagsstämma 2016 |
| 2016-08-31 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-25 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2016-02-24 | - | Årsstämma |
| 2016-02-04 | - | Bokslutskommuniké 2015 |
| 2015-11-13 | - | Kvartalsrapport 2015-Q3 |
| 2015-09-04 | - | Kvartalsrapport 2015-Q2 |
| 2015-07-22 | - | Extra Bolagsstämma 2015 |
| 2015-05-07 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2015-05-06 | - | Årsstämma |
| 2015-04-17 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-20 | - | Bokslutskommuniké 2014 |
| 2014-12-17 | - | Extra Bolagsstämma 2014 |
| 2014-11-28 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-14 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-29 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-12 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2014-06-11 | - | Årsstämma |
| 2014-05-16 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-21 | - | Bokslutskommuniké 2013 |
| 2013-11-15 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-17 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2013-06-14 | - | Årsstämma |
| 2013-05-17 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-22 | - | Bokslutskommuniké 2012 |
| 2012-11-30 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-31 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-20 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2012-06-19 | - | Årsstämma |
| 2012-04-20 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-21 | - | Bokslutskommuniké 2011 |
| 2011-11-04 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-12 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-06 | - | Kvartalsrapport 2011-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
iZafe Group AB ("iZafe Group" or the “Company”) hereby announces that that the Spanish company Ti-Medi has acquired approximately five percent of the shares in the Company, which makes Ti-Medi one of iZafe Group's largest shareholders. Ti-Medi has in total acquired 12,529,309 shares at the price of SEK 0.29 per share through a block deal brokered by Mangold Fondkommission.
Ti-Medi is a global company active in the manufacturing and distribution of technical solutions for compliance in pharmaceutical management. Ti-Medi sells dose packaging machines to over 650 pharmacies in Spain and Portugal.
For more information, see Ti-Medi's website, www.ti-medi.com/en.
"Our assessment is that the demand for iZafe Group's products and services will increase in the markets where we operate. We have long been looking for a company that develops and offers its customers precisely these types of services. Therefore, we have decided to invest in iZafe Group and we also hope to be able to find a good collaboration in the future to bring iZafe's products and services into Ti-Medi's product range in order to be able to offer these to our customers," says Marc Tarruell Tibau, co-founder of Ti-Medi
"The company has now gained a new strong and long-term owner that contributes with expertise and a global network. We view this very positively and interpret the investment as proof that iZafe Group's product and operations have support among knowledgeable market colleagues. We look forward to sharing the knowledge that Ti-Medi possesses about distribution in Southern Europe and initiating discussions about a future collaboration", says Anders Segerström, CEO of iZafe Group AB
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafe.se/investor-relations/
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution and the connected dose bag Pilloxa. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se. Further information is available at www.izafe.se/investor-relations/.